KRAS and colorectal carcinoma: Other proposed strategies targetting KRAS in CRC include using compounds to target G4 motifs present in the human KRAS promoter [111,112,113] and microRNAs to regulate the expression of KRAS or associated genes in the KRAS-driven pathway [114,115,116].